|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
3
|
Weis SM and Cheresh DA: Tumor
angiogenesis: molecular pathways and therapeutic targets. Nat Med.
17:1359–1370. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carmeliet P and Jain RK: Molecular
mechanisms and clinical applications of angiogenesis. Nature.
473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Croce CM: miRNAs in the spotlight:
understanding cancer gene dependency. Nat Med. 17:935–936. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Su Y, Li X, Ji W, et al: Small molecule
with big role: microRNAs in cancer metastatic microenvironments.
Cancer Lett. 344:147–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eilken HM and Adams RH: Turning on the
angiogenic microswitch. Nat Med. 16:853–854. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Conteduca V, Kopf B, Burgio SL, Bianchi E,
Amadori D and De Giorgi U: The emerging role of anti-angiogenic
therapy in ovarian cancer (Review). Int J Oncol. 44:1417–1424.
2014.PubMed/NCBI
|
|
9
|
Finnerty JR, Wang WX, Hébert SS, Wilfred
BR, Mao G and Nelson PT: The miR-15/107 group of microRNA genes:
evolutionary biology, cellular functions, and roles in human
diseases. J Mol Biol. 402:491–509. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Flavin RJ, Smyth PC, Laios A, et al:
Potentially important microRNA cluster on chromosome 17p13.1 in
primary peritoneal carcinoma. Mod Pathol. 22:197–205. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang L, Huang J, Yang N, et al: microRNAs
exhibit high frequency genomic alterations in human cancer. Proc
Natl Acad Sci USA. 103:9136–9141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tahiri A, Leivonen SK, Lüders T, et al:
Deregulation of cancer-related miRNAs is a common event in both
benign and malignant human breast tumors. Carcinogenesis. 35:76–85.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Creevey L, Ryan J, Harvey H, et al:
MicroRNA-497 increases apoptosis in MYCN amplified
neuroblastoma cells by targeting the key cell cycle regulator
WEE1. Mol Cancer. 12:232013.PubMed/NCBI
|
|
14
|
Zhao WY, Wang Y, An ZJ, et al:
Downregulation of miR-497 promotes tumor growth and angiogenesis by
targeting HDGF in non-small cell lung cancer. Biochem Biophys Res
Commun. 435:466–471. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li D, Zhao Y, Liu C, et al: Analysis of
miR-195 and miR-497 expression, regulation and role in breast
cancer. Clin Cancer Res. 17:1722–1730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo ST, Jiang CC, Wang GP, et al:
MicroRNA-497 targets insulin-like growth factor 1 receptor and has
a tumour suppressive role in human colorectal cancer. Oncogene.
32:1910–1920. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim YW, Kim EY, Jeon D, et al:
Differential microRNA expression signatures and cell type-specific
association with Taxol resistance in ovarian cancer cells. Drug Des
Devel Ther. 8:293–314. 2014.PubMed/NCBI
|
|
18
|
Lajer CB, Garnæs E, Friis-Hansen L, et al:
The role of miRNAs in human papilloma virus (HPV)-associated
cancers: bridging between HPV-related head and neck cancer and
cervical cancer. Br J Cancer. 106:1526–1534. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Caramuta S, Lee L, Ozata DM, et al:
Clinical and functional impact of TARBP2 over-expression in
adrenocortical carcinoma. Endocr Relat Cancer. 20:551–564. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lionetti M, Musto P, Di Martino MT, et al:
Biological and clinical relevance of miRNA expression signatures in
primary plasma cell leukemia. Clin Cancer Res. 19:3130–3142. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Claesson-Welsh L and Welsh M: VEGFA and
tumour angiogenesis. J Intern Med. 273:114–127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Welti J, Loges S, Dimmeler S and Carmeliet
P: Recent molecular discoveries in angiogenesis and antiangiogenic
therapies in cancer. J Clin Invest. 123:3190–3200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Larsen AK, Ouaret D, El Ouadrani K and
Petitprez A: Targeting EGFR and VEGF(R) pathway cross-talk in tumor
survival and angiogenesis. Pharmacol Ther. 131:80–90. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Anand S and Cheresh DA: Emerging role of
micro-RNAs in the regulation of angiogenesis. Genes Cancer.
2:1134–1138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou B, Ma R, Si W, et al: MicroRNA-503
targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.
Cancer Lett. 333:159–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun CY, She XM, Qin Y, et al: miR-15a and
miR-16 affect the angiogenesis of multiple myeloma by targeting
VEGF. Carcinogenesis. 34:426–435. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng X, Chopp M, Lu Y, Buller B and Jiang
F: MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis
via NRP-2 and MMP-3. Cancer Lett. 329:146–154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Q, Liu LZ, Qian X, et al: MiR-145
directly targets p70S6K1 in cancer cells to inhibit tumor growth
and angiogenesis. Nucleic Acids Res. 40:761–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang H, Pu J, Qi T, et al: MicroRNA-145
inhibits the growth, invasion, metastasis and angiogenesis of
neuroblastoma cells through targeting hypoxia-inducible factor 2
alpha. Oncogene. 33:387–397. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yin R, Bao W, Xing Y, Xi T and Gou S:
MiR-19b-1 inhibits angiogenesis by blocking cell cycle progression
of endothelial cells. Biochem Biophys Res Commun. 417:771–776.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Saharinen P, Eklund L, Pulkki K, Bono P
and Alitalo K: VEGF and angiopoietin signaling in tumor
angiogenesis and metastasis. Trends Mol Med. 17:347–362. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eng L, Azad AK, Habbous S, et al: Vascular
endothelial growth factor pathway polymorphisms as prognostic and
pharmacogenetic factors in cancer: a systematic review and
meta-analysis. Clin Cancer Res. 18:4526–4537. 2012. View Article : Google Scholar
|
|
33
|
Yu L, Deng L, Li J, Zhang Y and Hu L: The
prognostic value of vascular endothelial growth factor in ovarian
cancer: a systematic review and meta-analysis. Gynecol Oncol.
128:391–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ferrara N: Pathways mediating
VEGF-independent tumor angiogenesis. Cytokine Growth Factor Rev.
21:21–26. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu Q, Jiang Y, Yin Y, et al: A regulatory
circuit of miR-148a/152 and DNMT1 in modulating cell transformation
and tumor angiogenesis through IGF-IR and IRS1. J Mol Cell Biol.
5:3–13. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
DA Silva ND Jr, Fernandes T, Soci UP,
Monteiro AW, Phillips MI and DE Oliveira EM: Swimming training in
rats increases cardiac microRNA-126 expression and angiogenesis.
Med Sci Sports Exerc. 44:1453–1462. 2012.PubMed/NCBI
|
|
37
|
Bao L, Yan Y, Xu C, et al: MicroRNA-21
suppresses PTEN and hSulf-1 expression and promotes hepatocellular
carcinoma progression through AKT/ERK pathways. Cancer Lett.
337:226–236. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chan JK, Kiet TK, Blansit K, et al:
MiR-378 as a biomarker for response to anti-angiogenic
treatment in ovarian cancer. Gynecol Oncol. 133:568–574. 2014.
View Article : Google Scholar
|
|
39
|
Pecot CV, Rupaimoole R, Yang D, et al:
Tumour angiogenesis regulation by the miR-200 family. Nat Commun.
4:24272013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vecchione A, Belletti B, Lovat F, et al: A
microRNA signature defines chemoresistance in ovarian cancer
through modulation of angiogenesis. Proc Natl Acad Sci USA.
110:9845–9850. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lai Y, Zhang X, Zhang Z, et al: The
microRNA-27a: ZBTB10-specificity protein pathway is involved in
follicle stimulating hormone-induced VEGF, Cox2 and survivin
expression in ovarian epithelial cancer cells. Int J Oncol.
42:776–784. 2013.
|
